Weed Inc (PK:BUDZ)

Business Focus: Biotechnology & Medical Research

Sector:  Healthcare Industry:  Biotechnology & Medical Research
 
See Regulatory Filings on SEC
Company Contact
Address: 4920 N Post Trl
TUCSON AZ 85750-7111
Tel: N/A
Website: N/A
IR: N/A
<
Key People
Glen E. Martin
President, Chief Executive Officer, Chief Financial Officer, Director
Nicole M. Breen
Secretary, Treasurer, Director
 
Business Overview
WEED, Inc. is engaged in the business involving the purchase of land and building commercial grade cultivation centers to consult, assist, manage and lease to licensed dispensary owners and organic grow operators on a contract basis, with a concentration on the legal and medical marijuana sector. The Company and its subsidiaries are focused on various business opportunities in the cannabis and hemp field, including, but not limited to both indoor and outdoor grows, cultivations and harvest for research, product development, processing and manufacturing of both Pharma and non-Pharma products, services, therapeutics, and treatments on a global basis for both the medical cannabis and hemp global market space. The Company, through its subsidiary, Sangre AT, LLC, doing business as Sangre AgroTech, is engaged in genomic sequencing, genetics-based breeding, plant tissue culture, and plant biochemistry. Its other subsidiaries include WEED Israel Cannabis Ltd, WEED Australia Ltd, and others.
Financial Overview
For the fiscal year ended 31 December 2023, Weed Inc revenues was not reported. Net loss decreased 98% to $32K. Lower net loss reflects COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH segment loss decrease of 49% to $771K.
Employees: 2 as of Dec 31, 2023
Reporting Currency: U.S. Dollars
Enterprise value: $9.88M as of Dec 31, 2023
Annual revenue (TTM): $0.00M as of Dec 31, 2023
EBITDA (TTM): -$0.71M as of Dec 31, 2023
Net annual income (TTM): -$0.03M as of Dec 31, 2023
Free cash flow (TTM): -$1.08M as of Dec 31, 2023
Net Debt Last Fiscal Year: N/A
Shares outstanding: 123,482,685 as of Mar 29, 2024
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.